Bandingkan Harga & Kinerja Indo Oil Perkasa Tbk. (OILS) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Indo Oil Perkasa Tbk. dan Organon Pharma Indonesia Tbk.: Indo Oil Perkasa Tbk. diperdagangkan di Rp312 (kapitalisasi pasar 136,22 M, volume 24 jam 104,97 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Indo Oil Perkasa Tbk. lebih besar dari sisi kapitalisasi pasar. Mana yang lebih baik tergantung tujuan investasimu.
| OILS | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 136,22 M | 104,4 M |
Volume | 104,97 jt | — |
Lot | 1,05 jt | — |
Perputaran | 34,91 M | — |
Harga Rata-rata | 332,57 | — |
Nilai Transaksi | 34,91 M | — |
Harga Ekuilibrium Indikatif | 312 | — |
Volume Ekuilibrium Indikatif | 3,49 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Indo Oil Perkasa Tbk.
PT Indo Oil Perkasa Tbk (the Company) was established in Mojokerto based on the Notarial Deed No. 02 of Dr. CH. Anggia Ika HDKW., S.H. M.Hum, dated January 05, 2016. The Company commenced its commercial operations in 2017.
Selengkapnya di halaman OILS →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
